Clinical Trial: A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia
Brief Summary: The purpose of this study is to assess the cholesterol lowering effects of an investigational drug in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.
Current Primary Outcome: Plasma LDL-C.
Original Primary Outcome:
Current Secondary Outcome: Plasma HDL-C, non-HDL-C, and TG. Tolerability
Original Secondary Outcome:
Information By: Merck Sharp & Dohme Corp.
Dates:
Date Received: October 7, 2004
Date Started: November 2004
Date Completion:
Last Updated: March 13, 2017
Last Verified: March 2017